34 results on '"Banks, Matthew L."'
Search Results
2. A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys
- Author
-
Townsend, E. Andrew, Bremer, Paul T., Jacob, Nicholas T., Negus, S. Stevens, Janda, Kim D., and Banks, Matthew L.
- Published
- 2021
- Full Text
- View/download PDF
3. Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
- Author
-
Townsend, E. Andrew, Negus, S. Stevens, Poklis, Justin L., and Banks, Matthew L.
- Published
- 2020
- Full Text
- View/download PDF
4. Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone
- Author
-
Schwienteck, Kathryn L., Blake, Steven, Bremer, Paul T., Poklis, Justin L., Townsend, E. Andrew, Negus, S. Stevens, and Banks, Matthew L.
- Published
- 2019
- Full Text
- View/download PDF
5. Xylazine does not enhance fentanyl reinforcement in rats: A behavioral economic analysis
- Author
-
St. Onge, Celsey M., Canfield, Jeremy R., Ortiz, Allison, Sprague, Jon E., and Banks, Matthew L.
- Published
- 2024
- Full Text
- View/download PDF
6. Maintenance on naltrexone + amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys
- Author
-
Moerke, Megan J., Banks, Matthew L., Cheng, Kejun, Rice, Kenner C., and Negus, S. Stevens
- Published
- 2017
- Full Text
- View/download PDF
7. Effects of 21-day d-amphetamine and risperidone treatment on cocaine vs food choice and extended-access cocaine intake in male rhesus monkeys
- Author
-
Hutsell, Blake A., Negus, S. Stevens, and Banks, Matthew L.
- Published
- 2016
- Full Text
- View/download PDF
8. Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats
- Author
-
Robinson, Hannah L., Nicholson, Katherine L., Shelton, Keith L., Hamilton, Peter J., and Banks, Matthew L.
- Published
- 2023
- Full Text
- View/download PDF
9. Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats
- Author
-
Hutsell, Blake A., Baumann, Michael H., Partilla, John S., Banks, Matthew L., Vekariya, Rakesh, Glennon, Richard A., and Negus, S. Stevens
- Published
- 2016
- Full Text
- View/download PDF
10. Pharmacodynamic characterization of insulin on MDMA-induced thermogenesis
- Author
-
Banks, Matthew L., Buzard, Sarah K., Gehret, Candice M., Monroy, Alexa N., Kenaston, M. Alexander, Mills, Edward M., and Sprague, Jon E.
- Published
- 2009
- Full Text
- View/download PDF
11. Role of d-amphetamine and d-methamphetamine as active metabolites of benzphetamine: Evidence from drug discrimination and pharmacokinetic studies in male rhesus monkeys.
- Author
-
Banks, Matthew L., Snyder, Rodney W., Fennell, Timothy R., and Negus, S. Stevens
- Subjects
- *
COCAINE-induced disorders , *AMPHETAMINES , *METHAMPHETAMINE , *METABOLITES , *PHARMACOKINETICS , *DRUG therapy , *THERAPEUTICS - Abstract
Benzphetamine is a Schedule III anorectic agent that is a prodrug for d -amphetamine and d -methamphetamine and may have utility as an “agonist” medication for cocaine use disorder treatment. This study evaluated the pharmacokinetic-pharmacodynamic profile of benzphetamine using a drug discrimination procedure in rhesus monkeys. The potency and time course of cocaine-like discriminative stimulus effects were compared for benzphetamine (10–18 mg/kg, intramuscular (IM)) and d -amphetamine (0.032–0.32 mg/kg, IM) in monkeys ( n = 3–4) trained to discriminate IM cocaine (0.32 mg/kg) from saline in a two-key food-reinforced discrimination procedure. Parallel pharmacokinetic studies in the same monkeys determined plasma benzphetamine, d -methamphetamine and/or d -amphetamine levels for correlation with behavioral effects. d -Amphetamine produced dose-dependent, time-dependent, and full cocaine-like effects, i.e. ≥ 90% cocaine-appropriate responding, in all monkeys without altering response rates. The time course of d -amphetamine's cocaine-like discriminative stimulus effects correlated with plasma d -amphetamine levels. Benzphetamine was 180-fold less potent than d -amphetamine and produced full cocaine-like effects in only 2 of 4 monkeys while significantly decreasing response rates. Benzphetamine administration increased plasma d -methamphetamine (peak at 100 min) and d -amphetamine (peak at 24 h) levels, but the time course of behavioral effects did not correlate with increased levels of benzphetamine, d -methamphetamine or d -amphetamine. These results suggest that benzphetamine yields d -amphetamine and d -methamphetamine as active metabolites in rhesus monkeys, but generation of these metabolites is not sufficient to account for benzphetamine behavioral effects. The incomplete cocaine substitution profile and protracted d -amphetamine plasma levels suggest that benzphetamine may still warrant further evaluation as a candidate pharmacotherapy for cocaine use disorder treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Insights from Preclinical Choice Models on Treating Drug Addiction.
- Author
-
Banks, Matthew L. and Negus, S. Stevens
- Subjects
- *
SUBSTANCE abuse treatment , *TARGETED drug delivery , *PUBLIC health , *DRUG administration , *MOTOR ability , *DRUG addiction - Abstract
Substance-use disorders are a global public health problem that arises from behavioral misallocation between drug use and more adaptive behaviors maintained by nondrug alternatives (e.g., food or money). Preclinical drug self-administration procedures that incorporate a concurrently available nondrug reinforcer (e.g., food) provide translationally relevant and distinct dependent measures of behavioral allocation (i.e., to assess the relative reinforcing efficacy of the drug) and behavioral rate (i.e., to assess motor competence). In particular, preclinical drug versus food ‘choice’ procedures have produced increasingly concordant results with both human laboratory drug self-administration studies and double-blind placebo-controlled clinical trials. Accordingly, here we provide a heuristic framework of substance-use disorders based on a behavioral-centric perspective and recent insights from these preclinical choice procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. Development of a translational model to screen medications for cocaine use disorder I: Choice between cocaine and food in rhesus monkeys.
- Author
-
Johnson, Amy R., Banks, Matthew L., Blough, Bruce E., Lile, Joshua A., Nicholson, Katherine L., and Negus, S. Stevens
- Subjects
- *
SUBSTANCE-induced disorders , *DRUGS , *RHESUS monkeys , *HOMOLOGOUS chromosomes , *INTRAVENOUS catheterization , *ANIMAL experimentation , *COCAINE , *DECISION making , *DOSE-effect relationship in pharmacology , *FOOD , *MEDICAL research , *PRIMATES , *REINFORCEMENT (Psychology) , *RESEARCH funding , *SELF medication , *PHARMACODYNAMICS - Abstract
Background: Homologous cocaine self-administration procedures in laboratory animals and humans may facilitate translational research for medications development to treat cocaine dependence. This study, therefore, sought to establish choice between cocaine and an alternative reinforcer in rhesus monkeys responding under a procedure back-translated from previous human studies and homologous to a human laboratory procedure described in a companion paper.Methods: Four rhesus monkeys with chronic indwelling intravenous catheters had access to cocaine injections (0, 0.043, 0.14, or 0.43mg/kg/injection) and food (0, 1, 3, or 10 1g banana-flavored food pellets). During daily 5h sessions, a single cocaine dose and a single food-reinforcer magnitude were available in 10 30-min trials. During the initial "sample" trial, the available cocaine and food reinforcer were delivered non-contingently. During each of the subsequent nine "choice" trials, responding could produce either the cocaine or food reinforcer under an independent concurrent progressive-ratio schedule.Results: Preference was governed by the cocaine dose and food-reinforcer magnitude, and increasing cocaine doses produced dose-dependent increases in cocaine choice at all food-reinforcer magnitudes. Effects of the candidate medication lisdexamfetamine (0.32-3.2mg/kg/day) were then examined on choice between 0.14mg/kg/injection cocaine and 10 pellets. Under baseline conditions, this reinforcer pair maintained an average of approximately 6 cocaine and 3 food choices. Lisdexamfetamine dose-dependently decreased cocaine choice in all monkeys, but food choice was not significantly altered.Conclusions: These results support utility of this procedure in rhesus monkeys as one component of a platform for translational research on medications development to treat cocaine use disorder. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
14. Effects of 7-day repeated treatment with the 5-HT2A inverse agonist/antagonist pimavanserin on methamphetamine vs. food choice in male rhesus monkeys.
- Author
-
Banks, Matthew L.
- Subjects
- *
CIRCUMCELLIONS , *METHAMPHETAMINE , *RHESUS monkeys , *SEROTONIN receptors , *ENEMIES , *ANIMAL experimentation , *BIOLOGICAL models , *COMPARATIVE studies , *DECISION making , *DRUG interactions , *DRUG administration , *DOSE-effect relationship in pharmacology , *FOOD , *FOOD habits , *RESEARCH methodology , *MEDICAL cooperation , *PIPERIDINE , *PRIMATES , *REINFORCEMENT (Psychology) , *RESEARCH , *RESEARCH funding , *SELF medication , *SEROTONIN antagonists , *UREA , *SEROTONIN agonists , *EVALUATION research , *TREATMENT effectiveness - Abstract
Background: Preclinical drug vs. food choice is an emerging group of drug self-administration procedures that have shown predictive validity to clinical drug addiction. Emerging data suggest that serotonin (5-HT)2A receptors modulate mesolimbic dopamine function, such that 5-HT2A antagonists blunt the abuse-related neurochemical effects of monoamine transporter substrates, such as amphetamine or methamphetamine. Whether subchronic 5-HT2A antagonist treatment attenuates methamphetamine reinforcement in any preclinical drug self-administration procedure is unknown. The study aim was therefore to determine 7-day treatment effects with the 5-HT2A inverse agonist/antagonist pimavanserin on methamphetamine vs. food choice in monkeys.Methods: Behavior was maintained under a concurrent schedule of food delivery (1g pellets, fixed-ratio 100 schedule) and intravenous methamphetamine injections (0-0.32 mg/kg/injection, fixed-ratio 10 schedule) in male rhesus monkeys (n=3). Methamphetamine choice dose-effect functions were determined daily before and during 7-day repeated pimavanserin (1.0-10mg/kg/day, intramuscular) treatment periods.Results: Under control conditions, increasing methamphetamine doses resulted in a corresponding increase in methamphetamine vs. food choice. Repeated pimavanserin administration failed to attenuate methamphetamine choice and produce a reciprocal increase in food choice in any monkey up to doses (3.2-10mg/kg) that suppressed rates of operant responding primarily during components where behavior was maintained by food pellets.Conclusions: Repeated 5-HT2A receptor inverse agonist/antagonist treatment did not attenuate methamphetamine reinforcement under a concurrent schedule of intravenous methamphetamine and food presentation in nonhuman primates. Overall, these results do not support the therapeutic potential of 5-HT2A inverse agonists/antagonists as candidate medications for methamphetamine addiction. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
15. Relationship between discriminative stimulus effects and plasma methamphetamine and amphetamine levels of intramuscular methamphetamine in male rhesus monkeys.
- Author
-
Banks, Matthew L., Smith, Douglas A., Kisor, David F., and Poklis, Justin L.
- Subjects
- *
METHAMPHETAMINE , *STIMULUS & response (Psychology) , *INTRAMUSCULAR injections , *DRUG abuse , *DRUG metabolism , *BLOOD plasma - Abstract
Methamphetamine is a globally abused drug that is metabolized to amphetamine, which also produces abuse-related behavioral effects. However, the contributing role of methamphetamine metabolism to amphetamine in methamphetamine's abuse-related subjective effects is unknown. This preclinical study was designed to determine 1) the relationship between plasma methamphetamine levels and methamphetamine discriminative stimulus effects and 2) the contribution of the methamphetamine metabolite amphetamine in the discriminative stimulus effects of methamphetamine in rhesus monkeys. Adult male rhesus monkeys (n = 3) were trained to discriminate 0.18 mg/kg intramuscular (+)-methamphetamine from saline in a two-key food-reinforced discrimination procedure. Time course of saline, (+)-methamphetamine (0.032–0.32 mg/kg), and (+)-amphetamine (0.032–0.32 mg/kg) discriminative stimulus effects were determined. Parallel pharmacokinetic studies were conducted in the same monkeys to determine plasma methamphetamine and amphetamine levels after methamphetamine administration and amphetamine levels after amphetamine administration for correlation with behavior in the discrimination procedure. Both methamphetamine and amphetamine produced full, ≥ 90%, methamphetamine-like discriminative stimulus effects. Amphetamine displayed a slightly, but significantly, longer duration of action than methamphetamine in the discrimination procedure. Both methamphetamine and amphetamine behavioral effects were related to methamphetamine and amphetamine plasma levels by a clockwise hysteresis loop indicating acute tolerance had developed to the discriminative stimulus effects. Furthermore, amphetamine levels after methamphetamine administration were absent when methamphetamine stimulus effects were greatest and peaked when methamphetamine discriminative stimulus effects returned to saline-like levels. Overall, these results demonstrate the methamphetamine metabolite amphetamine does not contribute to methamphetamine's abuse-related subjective effects. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys.
- Author
-
Schwienteck, Kathryn L. and Banks, Matthew L.
- Subjects
- *
METHYLPHENIDATE , *AMPHETAMINES , *PHENYLACETATES , *COCAINE abuse , *CENTRAL nervous system stimulants , *ADRENERGIC uptake inhibitors , *ANIMAL experimentation , *COCAINE , *DECISION making , *DRUG administration , *DOSE-effect relationship in pharmacology , *FOOD , *METHAMPHETAMINE , *PRIMATES , *RESEARCH funding , *SELF medication , *DEXTROAMPHETAMINE , *PHARMACODYNAMICS - Abstract
Background: Methamphetamine addiction is a significant public health problem for which no Food and Drug Administration-approved pharmacotherapies exist. Preclinical drug vs. food choice procedures have been predictive of clinical medication efficacy in the treatment of opioid and cocaine addiction. Whether preclinical choice procedures are predictive of candidate medication effects for other abused drugs, such as methamphetamine, remains unclear. The present study aim was to determine continuous 7-day treatment effects with the monoamine releaser d-amphetamine and the monoamine uptake inhibitor methylphenidate on methamphetamine vs. food choice. In addition, 7-day cocaine treatment effects were also examined.Methods: Behavior was maintained under a concurrent schedule of food delivery (1-g pellets, fixed-ratio 100 schedule) and methamphetamine injections (0-0.32mg/kg/injection, fixed-ratio 10 schedule) in male rhesus monkeys (n=4). Methamphetamine choice dose-effect functions were determined daily before and during 7-day periods of continuous intravenous treatment with d-amphetamine (0.01-0.1mg/kg/h), methylphenidate (0.032-0.32mg/kg/h), or cocaine (0.1-0.32mg/kg/h).Results: During saline treatment, increasing methamphetamine doses resulted in a corresponding increase in methamphetamine vs. food choice. Continuous 7-day treatments with d-amphetamine, methylphenidate or cocaine did not significantly attenuate methamphetamine vs. food choice up to doses that decreased rates of operant responding. However, 0.1mg/kg/h d-amphetamine did eliminate methamphetamine choice in two monkeys.Conclusions: The present subchronic treatment results support the utility of preclinical methamphetamine choice to evaluate candidate medications for methamphetamine addiction. Furthermore, these results confirm and extend previous results demonstrating differential pharmacological mechanisms between cocaine choice and methamphetamine choice. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
17. Effects of environmental and pharmacological manipulations on a novel delayed nonmatching-to-sample ‘working memory’ procedure in unrestrained rhesus monkeys.
- Author
-
Hutsell, Blake A. and Banks, Matthew L.
- Subjects
- *
SHORT-term memory , *EXECUTIVE function , *METHYLPHENIDATE , *TETRAHYDROCANNABINOL , *LABORATORY monkeys - Abstract
Background Working memory is a domain of ‘executive function.’ Delayed nonmatching-to-sample (DNMTS) procedures are commonly used to examine working memory in both human laboratory and preclinical studies. New method The aim was to develop an automated DNMTS procedure maintained by food pellets in rhesus monkeys using a touch-sensitive screen attached to the housing chamber. Specifically, the DNMTS procedure was a 2-stimulus, 2-choice recognition memory task employing unidimensional discriminative stimuli and randomized delay interval presentations. Results DNMTS maintained a delay-dependent decrease in discriminability that was independent of the retention interval distribution. Eliminating reinforcer availability during a single delay session or providing food pellets before the session did not systematically alter accuracy, but did reduce total choices. Increasing the intertrial interval enhanced accuracy at short delays. Acute Δ 9 -THC pretreatment produced delay interval-dependent changes in the forgetting function at doses that did not alter total choices. Acute methylphenidate pretreatment only decreased total choices. Comparison with existing methods All monkeys were trained to perform NMTS at the 1 s training delay within 60 days of initiating operant touch training. Furthermore, forgetting functions were reliably delay interval-dependent and stable over the experimental period (∼6 months). Conclusions Consistent with previous studies, increasing the intertrial interval improved DNMTS performance, whereas Δ 9 -THC disrupted DNMTS performance independent of changes in total choices. Overall, the touchscreen-based DNMTS procedure described provides an efficient method for training and testing experimental manipulations on working memory in unrestrained rhesus monkeys. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
18. Synthetic cathinones ("bath salts").
- Author
-
Banks, Matthew L, Worst, Travis J, Rusyniak, Daniel E, and Sprague, Jon E
- Subjects
- *
SUBSTANCE abuse treatment , *SUBSTANCE abuse diagnosis , *SYNTHETIC cathinone , *CENTRAL nervous system stimulants , *DESIGNER drugs , *PSYCHIATRIC drugs , *ALKALOIDS , *RESEARCH funding - Abstract
Background: Synthetic cathinones are popularly referred to in the media as "bath salts." Through the direct and indirect activation of the sympathetic nervous system, smoking, snorting, or injecting synthetic cathinones can result in tachycardia, hypertension, hyperthermia, myocardial infarction, and death.Objective: The chemical structures and names of bath salts identified by the Ohio Attorney General's Bureau of Criminal Investigation are presented. Based on their common pharmacophores, we review the history, pharmacology, toxicology, detection methods, and clinical implications of synthetic cathinones. Through the integration of this information, the pharmacological basis for the management of patients using synthetic cathinones is presented.Discussion: Synthetic cathinones activate central serotonergic and dopaminergic systems contributing to acute psychosis and the peripheral activation of the sympathetic nervous system. The overstimulation of the sympathetic nervous system contributes to the many toxicities reported with bath salt use. The pharmacological basis for managing these patients is targeted at attenuating the activation of these systems.Conclusions: Treatment of patients presenting after using bath salts should be focused on reducing agitation and psychosis and supporting renal perfusion. The majority of successfully treated synthetic cathinones cases have used benzodiazepines and antipsychotics along with general supportive care. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
19. Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging.
- Author
-
Nader, Michael A. and Banks, Matthew L.
- Subjects
- *
DRUG abuse , *PRIMATES as laboratory animals , *COCAINE abuse , *BRAIN imaging , *POSITRON emission tomography - Abstract
The current review highlights the importance of environmental variables on cocaine self-administration in nonhuman primate models of drug abuse. In addition to describing the behavioral consequences, potential mechanisms of action are discussed, based on imaging results using the non-invasive and translational technique of positron emission tomography (PET). In this review, the role of three environmental variables – both positive and negative – are described: alternative non-drug reinforcers; social rank (as an independent variable) and punishment of cocaine self-administration. These environmental stimuli can profoundly influence brain function and drug self-administration. We focus on environmental manipulations involving non-drug alternatives (e.g., food reinforcement) using choice paradigms. Manipulations such as response cost and social variables (e.g., social rank, social stress) also influence the behavioral effects of drugs. Importantly, these manipulations are amenable to brain imaging studies. Taken together, these studies emphasize the profound impact environmental variables can have on drug taking, which should provide important information related to individual-subject variability in treatment responsiveness, and the imaging work may highlight pharmacological targets for medications related to treating drug abuse. This article is part of a Special Issue entitled ‘NIDA 40th Anniversary Issue’. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
20. Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys.
- Author
-
Banks, Matthew L., Blough, Bruce E., and Negus, S. Stevens
- Subjects
- *
APPETITE depressants , *COCAINE abuse , *PRODRUGS , *FOOD , *RHESUS monkeys , *AMPHETAMINE abuse , *TREATMENT duration , *INTRAVENOUS therapy - Abstract
Abstract: Background: The clinical utility of monoamine releasers such as phenmetrazine or d-amphetamine as candidate agonist medications for cocaine dependence is hindered by their high abuse liability. Phendimetrazine is a clinically available schedule III anorectic that functions as a prodrug for phenmetrazine and thus may have lower abuse liability. This study determined the effects of continuous 14-day treatment with phendimetrazine on cocaine vs. food choice in rhesus monkeys (N =4). Methods: Responding was maintained under a concurrent schedule of food delivery (1-g pellets, fixed-ratio 100 schedule) and cocaine injections (0–0.1mg/kg/injection, fixed-ratio 10 schedule). Cocaine choice dose–effect curves were determined daily before and during 14-day periods of continuous intravenous treatment with saline or (+)-phendimetrazine (0.32–1.0mg/kg/h). Effects of 14-day treatment with (+)-phenmetrazine (0.1–0.32mg/kg/h; N =5) and d-amphetamine (0.032–0.1mg/kg/h; N =6) were also examined for comparison. Results: During saline treatment, food was primarily chosen during availability of low cocaine doses (0, 0.0032, and 0.01mg/kg/injection), and cocaine was primarily chosen during availability of higher cocaine doses (0.032 and 0.1mg/kg/injection). Phendimetrazine initially decreased overall responding without significantly altering cocaine choice. Over the course of 14 days, tolerance developed to rate decreasing effects, and phendimetrazine dose-dependently decreased cocaine choice (significant at 0.032mg/kg/injection cocaine). Phenmetrazine and d-amphetamine produced qualitatively similar effects. Conclusions: These results demonstrate that phendimetrazine can produce significant, though modest, reductions in cocaine choice in rhesus monkeys. Phendimetrazine may be especially suitable as a candidate medication for human studies because of its schedule III clinical availability. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
21. Role of phenmetrazine as an active metabolite of phendimetrazine: Evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys
- Author
-
Banks, Matthew L., Blough, Bruce E., Fennell, Timothy R., Snyder, Rodney W., and Negus, S. Stevens
- Subjects
- *
PHENETHYLAMINES , *DRUG discrimination (Pharmacology) , *PHARMACOKINETICS , *RHESUS monkeys , *LABORATORY monkeys , *AMPHETAMINES , *DOPAMINE , *NORADRENALINE - Abstract
Abstract: Background: Monoamine releasers such as d-amphetamine that selectively promote release of dopamine/norepinephrine versus serotonin are one class of candidate medications for treating cocaine dependence; however, their clinical utility is limited by undesirable effects such as abuse liability. Clinical utility of these compounds may be increased by development of prodrugs to reduce abuse potential by slowing onset of drug effects. This study examined the behavioral and pharmacokinetic profile of the Schedule III compound phendimetrazine, which may serve as a prodrug for the N-demethylated metabolite and potent dopamine/norepinephrine releaser phenmetrazine. Methods: Monkeys (n =5) were trained in a two-key food-reinforced discrimination procedure to discriminate cocaine (0.32mg/kg, IM) from saline, and the potency and time course of cocaine-like discriminative stimulus effects were determined for (+)-phenmetrazine, (−)-phenmetrazine, (+)-phendimetrazine, (−)-phendimetrazine, and (±)-phendimetrazine. Parallel pharmacokinetic studies in the same monkeys examined plasma phenmetrazine and phendimetrazine levels for correlation with cocaine-like discriminative stimulus effects. Results: Both isomers of phenmetrazine, and the racemate and both isomers of phendimetrazine, produced dose- and time-dependent substitution for the discriminative stimulus effects of cocaine, with greater potency residing in the (+) isomers. In general, plasma phenmetrazine levels increased to similar levels after administration of behaviorally active doses of either phenmetrazine or phendimetrazine. Conclusions: These results support the hypothesis that phenmetrazine is an active metabolite that contributes to the effects of phendimetrazine. However, behavioral effects of phendimetrazine had a more rapid onset than would have been predicted by phenmetrazine levels alone, suggesting that other mechanisms may also contribute. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
22. Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics
- Author
-
Banks, Matthew L., Folk, John E., Rice, Kenner C., and Negus, S. Stevens
- Subjects
- *
FENTANYL , *PAIN management , *KETAMINE , *RHESUS monkeys , *OPIOID receptors , *METHYL aspartate , *BIOLOGICAL assay - Abstract
Abstract: Mu-opioid receptor agonists such as fentanyl are effective analgesics, but their clinical use is limited by untoward effects. Adjunct medications may improve the effectiveness and/or safety of opioid analgesics. This study compared interactions between fentanyl and either the noncompetitive N-methyl-D-aspartate (NMDA) glutamate receptor antagonist ketamine or the delta-opioid receptor agonist SNC162 [(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-phenyl)methyl]-N,N-diethylbenzamide] in two behavioral assays in rhesus monkeys. An assay of thermal nociception evaluated tail-withdrawal latencies from water heated to 50 and 54°C. An assay of schedule-controlled responding evaluated response rates maintained under a fixed-ratio 30 schedule of food presentation. Effects of each drug alone and of three mixtures of ketamine+fentanyl (22:1, 65:1, 195:1 ketamine/fentanyl) or SNC162+fentanyl (59:1, 176:1, 528:1 SNC162/fentanyl) were evaluated in each assay. All drugs and mixtures dose-dependently decreased rates of food-maintained responding, and drug proportions in the mixtures were based on relative potencies in this assay. Ketamine and SNC162 were inactive in the assay of thermal antinociception, but fentanyl and all mixtures produced dose-dependent antinociception. Drug interactions were evaluated using dose-addition and dose-ratio analysis. Dose-addition analysis revealed that interactions for all ketamine/fentanyl mixtures were additive in both assays. SNC162/fentanyl interactions were usually additive, but one mixture (176:1) produced synergistic antinociception at 50°C. Dose-ratio analysis indicated that ketamine failed to improve the relative potency of fentanyl to produce antinociception vs. rate suppression, whereas two SNC162/fentanyl mixtures (59:1 and 176:1) increased the relative potency of fentanyl to produce antinociception. These results suggest that delta agonists may produce more selective enhancement than ketamine of mu agonist-induced antinociception. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
23. A model for motivating PharmD students to pursue a PhD degree.
- Author
-
Banks, Matthew L., Haynes, Kevin, and Sprague, Jon E.
- Abstract
Abstract: Objective: To evaluate a mechanism designed to encourage pharmacy students to purse a PhD degree. Design: A model in use at Ohio Northern University (ONU)''s College of Pharmacy is described and provides research experiences and motivation for pharmacy students to pursue a PhD degree. The model described establishes a method for the recruitment and funding of undergraduate and pharmacy research students in a pharmacology laboratory. Assessment: Since 1997, the pharmacology laboratory has trained approximately 30 undergraduate and pharmacy students. These students have participated in research projects that led to more than 20 peer-reviewed publications. Former students from the laboratory were asked to fill out a web-based questionnaire of their research experience and its impact on career decisions. All respondents overwhelmingly agreed that the research experience aided in the learning of lecture material and in obtaining critical thinking skills in the practice of pharmacy. Furthermore, four of the students have earned a PhD degree and 10 students have other advanced degrees (e.g., MD, MSc). Conclusions: Although this model has been successfully used to encourage PharmD students to pursue a PhD degree in biomedical research, it can also be applied to any pharmacy discipline that offers a PhD degree program. Moreover, this model provides a template for encouraging pharmacy students to participate in biomedical research at liberal arts institutions with a primarily teaching focus. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
24. The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents.
- Author
-
Banks, Matthew L., Worst, Travis J., Rusyniak, Daniel E., and Sprague, Jon E.
- Subjects
- *
ADRENERGIC agonists , *SYMPATHOMIMETIC agents , *ADRENERGIC receptors , *ECSTASY (Drug) , *FEVER , *ALKALOIDS , *DESIGNER drugs , *PSYCHIATRIC drugs , *SUBSTANCE abuse , *CENTRAL nervous system stimulants - Published
- 2015
- Full Text
- View/download PDF
25. Corrigendum to “Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys” [Drug Alcohol Depend. 131 (2013) 204–213].
- Author
-
Banks, Matthew L., Blough, Bruce E., and Negus, S. Stevens
- Published
- 2013
- Full Text
- View/download PDF
26. Effects of environmental manipulations on cocaine-vs-social choice in male and female rats.
- Author
-
Marcus, Madison M., Negus, S. Stevens, and Banks, Matthew L.
- Subjects
- *
COCAINE-induced disorders , *REINFORCEMENT (Psychology) , *SOCIAL interaction , *ENVIRONMENTAL literacy , *INTRAVENOUS therapy , *RATS - Abstract
Cocaine use disorder occurs in an environment where cocaine and other nondrug commodities are concurrently available. Preclinical drug-vs-nondrug choice procedures are one simplified method of modeling this complex clinical environment. The present study established a discrete-trial cocaine-vs-social interaction choice procedure in male and female rats and determined sensitivity of choice behavior to manipulations of reinforcer magnitude and non-contingent "sample" reinforcer presentation. Rats could make up to nine discrete choices between an intravenous cocaine infusion (0.1–1.0 mg/kg/inf) and social interaction with a same-sex social "Partner" rat. Cocaine infusions were available under a progressive-ratio (PR) schedule of reinforcement, and social interaction was available under a fixed-ratio (FR) 3 schedule. Social interaction was chosen over no or small cocaine doses (saline, 0.01 mg/kg/inf) and behavior was reallocated away from social and towards cocaine at larger cocaine doses (1.0 mg/kg/inf). Manipulating social interaction time as one method to alter social reinforcer magnitude did not significantly alter cocaine-vs-social choice. Removing the non-contingent reinforcer presentations before the discrete choice trials also failed to affect cocaine-vs-social choice, suggesting the time interval was sufficient to minimize any potential influence of the non-contingent cocaine infusions on subsequent choice behavior. Overall, the present results were consistent with previous drug-vs-social choice studies and extend our knowledge of environmental factors impacting drug-vs-social choice. Future studies determining the pharmacological sensitivity of cocaine-vs-social choice will be important in expanding the preclinical utility of these procedures for candidate medication drug development. • Cocaine was chosen over social interaction in both female and male rats. • Manipulation of social access time failed to alter cocaine-vs-social choice. • Removing non-contingent reinforcer presentations did not attenuate cocaine choice. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. A generalized matching law analysis of cocaine vs. food choice in rhesus monkeys: effects of candidate 'agonist-based' medications on sensitivity to reinforcement.
- Author
-
Hutsell, Blake A, Negus, S Stevens, and Banks, Matthew L
- Abstract
Background: We have previously demonstrated reductions in cocaine choice produced by either continuous 14-day phendimetrazine and d-amphetamine treatment or removing cocaine availability under a cocaine vs. food choice procedure in rhesus monkeys. The aim of the present investigation was to apply the concatenated generalized matching law (GML) to cocaine vs. food choice dose-effect functions incorporating sensitivity to both the relative magnitude and price of each reinforcer. Our goal was to determine potential behavioral mechanisms underlying pharmacological treatment efficacy to decrease cocaine choice.Methods: A multi-model comparison approach was used to characterize dose- and time-course effects of both pharmacological and environmental manipulations on sensitivity to reinforcement.Results: GML models provided an excellent fit of the cocaine choice dose-effect functions in individual monkeys. Reductions in cocaine choice by both pharmacological and environmental manipulations were principally produced by systematic decreases in sensitivity to reinforcer price and non-systematic changes in sensitivity to reinforcer magnitude.Conclusions: The modeling approach used provides a theoretical link between the experimental analysis of choice and pharmacological treatments being evaluated as candidate 'agonist-based' medications for cocaine addiction. The analysis suggests that monoamine releaser treatment efficacy to decrease cocaine choice was mediated by selectively increasing the relative price of cocaine. Overall, the net behavioral effect of these pharmacological treatments was to increase substitutability of food pellets, a nondrug reinforcer, for cocaine. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
28. Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys
- Author
-
Gould, Robert W., Gage, H. Donald, Banks, Matthew L., Blaylock, Brandi L., Czoty, Paul W., and Nader, Michael A.
- Subjects
- *
ECSTASY (Drug) , *COCAINE , *SEROTONIN , *DOPAMINERGIC neurons , *POSITRON emission tomography , *DRUG development , *DRUG abuse , *LABORATORY monkeys - Abstract
Abstract: Cocaine self-administration alters brain dopaminergic and serotonergic function primarily in mesolimbic and prefrontal brain regions whereas 3,4-methylenedioxymethamphetamine (MDMA) self-administration predominately alters brain serotonergic function in a more widespread distribution across cortical regions. We previously reported that, compared to drug-naïve rhesus monkeys, self-administration of cocaine but not MDMA was associated with increased serotonin transporter (SERT) availability in two mesolimbic regions, the caudate nucleus and putamen, as measured by positron emission tomography (PET) using the SERT-specific ligand [11C]-3-amino-4(2-dimethylamino-methyl-phenylsulfanyl)-benzonitrile ([11C]DASB). The goal of the present study was to extend this comparison between cocaine and MDMA self-administration to SERT availability in cortical regions, which have been shown previously to be affected in human drug abusers and are associated with executive function. PET studies using [11C]DASB were conducted in adult male rhesus monkeys with a history of cocaine (mean intake = 742.6 mg/kg) or MDMA (mean intake = 121.0 mg/kg) self-administration, and drug-naïve controls (n = 4/group). Regions of interest were drawn for several cortical (prefrontal, temporal, parietal, occipital and midcingulate) and subcortical (thalamus, amygdala and hippocampus) areas. Cortical SERT availability was significantly higher in monkeys with a cocaine self-administration history compared to controls whereas MDMA self-administration resulted in lower levels of SERT availability. These data extend our previous findings indicating that cocaine and MDMA self-administration differentially alter SERT availability in subcortical and cortical regions, which may have implications for development of treatment drugs. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
29. Escalation of food-maintained responding and sensitivity to the locomotor stimulant effects of cocaine in mice
- Author
-
Goeders, James E., Murnane, Kevin S., Banks, Matthew L., and Fantegrossi, William E.
- Subjects
- *
REINFORCEMENT (Psychology) , *DRUG administration , *COCAINE abuse , *ANIMAL feeding behavior , *ANIMAL psychology testing , *LABORATORY mice - Abstract
Abstract: Escalation of drug self-administration is a consequence of extended drug access and is thought to be specifically related to addiction, but few studies have investigated whether intake of non-drug reinforcers may also escalate with extended-access. The goal of these studies was to determine the effects of limited and extended-access to food reinforcers on behavioral and pharmacological endpoints in mice. In distinct groups, responding on a lever was maintained by liquid reinforcement, or nose-poke responses were maintained by sucrose pellets or liquid food in sessions lasting 1 h (limited-access) or 10 h (extended-access). The reinforcing strength of each food, as well as reinforcer-associated cues, was tested before and after extended-access using a progressive ratio (PR) schedule, and locomotor activity in response to novelty and increasing doses of cocaine was assessed in an open field setting in all animals after access to food reinforcers. Escalation of lever-pressing behavior reinforced by liquid food, but not nose-poke behavior reinforced by liquid food or sucrose pellets, was observed across successive extended-access sessions. A concomitant increase in the reinforcing strength of liquid food and its associated cues was apparent in mice that escalated their responding, but not in mice that did not escalate. Finally, extended reinforcer access leading to behavioral escalation was accompanied by an increased sensitivity to the psychostimulant effects of cocaine compared to limited-access. These findings indicate that behavioral escalation can develop as a consequence of extended-access to a non-drug reinforcer, although both the nature of the reinforcer (liquid versus solid food) and the topography of the operant response (lever versus nose-poke) modulate its development. These data also suggest that some of the behavioral and pharmacological corrolaries of behavioral escalation observed following extended-access to drug self-administration may not be due to drug exposure, but rather, may result from basic behavioral processes which underlie operant responding maintained by appetitive stimuli. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
30. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
- Author
-
Schwienteck, Kathryn L., Faunce, Kaycee E., Rice, Kenner C., Obeng, Samuel, Zhang, Yan, Blough, Bruce E., Grim, Travis W., Negus, S. Stevens, and Banks, Matthew L.
- Subjects
- *
FENTANYL , *OPIOID receptors , *LIGANDS (Biochemistry) , *OPIOID abuse , *GENERATING functions , *DRUG efficacy - Abstract
Abstract One emerging strategy to address the opioid crisis is the development of mu opioid receptor (MOR) ligands that preferentially signal the G-protein vs. β-arrestin pathway. The present study compared the relative potency and effectiveness of two G-protein biased (GPB)-MOR ligands TRV130 and SR-14968 to five unbiased MOR ligands (NAQ, nalbuphine, buprenorphine, morphine, and methadone) on therapeutic-related (e.g. antinociception) and abuse-related (e.g. discriminative stimulus effects) endpoints. Male and female rats were tested in a warm water tail-withdrawal procedure (50 °C) or trained to discriminate fentanyl (0.04 mg/kg, SC) from saline in a two-lever food-reinforced discrimination procedure. TRV130 and SR-14968 were approximately two-fold more potent to produce fentanyl stimulus effects vs. antinociception. Morphine, fentanyl, and methadone were significantly more potent in the fentanyl discrimination vs. tail withdrawal procedure. In addition, maximum antinociceptive and discriminative stimulus effects of fixed-proportion fentanyl/naltrexone mixtures (1:0.018, 1:0.054, 1:0.18, 1:0.3, and 1:0.54) were used to quantify 1) the relative in vivo efficacy of the two GPB-MOR agonists and five unbiased MOR ligands, and 2) potential species differences in MOR ligand effects between rats and monkeys. The efficacy-effect function generated from the fentanyl/naltrexone mixtures stratified the five unbiased ligands consistent with agonist-stimulated GTPγS binding (NAQ = nalbuphine < buprenorphine < morphine < methadone). However, TRV130 and SR-14968 produced greater antinociception and less fentanyl-like stimulus effects than was predicted. Furthermore, there was a significant positive correlation between rat and monkey antinociceptive effects. Overall, these results demonstrate GPB-MOR agonists produce undesirable abuse-related effects, albeit with slightly better potency and efficacy ratios compared to unbiased agonists. This article is part of the Special Issue entitled 'Opioid Neuropharmacology: Advances in treating pain and opioid addiction'. Highlights • G-protein biased mu agonists produced fentanyl-like discriminative stimulus effects. • GPB-MOR agonists produced better potency and efficacy ratios than existing opioids. • Fixed-proportion fentanyl/naltrexone mixtures manipulate in vivo drug efficacy. • Mu agonist antinociceptive effects in rats and monkeys were positively correlated. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
31. Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys.
- Author
-
Cornelissen, Jeremy C., Steele, Floyd F., Tenney, Rebekah D., Obeng, Samuel, Rice, Kenner C., Zhang, Yan, and Banks, Matthew L.
- Subjects
- *
NOCICEPTIN , *OPIOIDS , *ANALGESICS , *RHESUS monkeys , *LIGANDS (Biochemistry) - Abstract
Abstract Mu-opioid receptor agonists are clinically effective analgesics, but also produce undesirable effects that limit their clinical utility. The nociceptin opioid peptide (NOP) receptor system also modulates nociception, and NOP agonists might be useful adjuncts to enhance the analgesic effects or attenuate the undesirable effects of mu-opioid agonists. The present study determined behavioral interactions between the NOP agonist (−)-Ro 64-6198 and mu-opioid ligands that vary in mu-opioid receptor efficacy (17-cyclopropylmethyl-3,14β-dihyroxy-4,5α-epoxy-6α-[(3 ́-isoquinolyl)acetamindo]morphinan (NAQ) < buprenorphine < nalbuphine < morphine = oxycodone < methadone) in male rhesus monkeys. For comparison, Ro 64-6198 interactions were also examined with the kappa-opioid receptor agonist nalfurafine. Each opioid ligand was examined alone and following fixed-dose Ro 64-6198 pretreatments in assays of thermal nociception (n = 3–4) and schedule-controlled responding (n = 3). Ro 64-6198 alone failed to produce significant antinociception up to doses (0.32 mg/kg, IM) that significantly decreased rates of responding. All opioid ligands, except NAQ and nalfurafine, produced dose- and thermal intensity-dependent antinociception. Ro 64-6198 enhanced the antinociceptive potency of buprenorphine, nalbuphine, methadone, and nalfurafine. Ro 64-6198 enhancement of nalbuphine antinociception was NOP antagonist SB-612111 reversible and occurred under a narrow range of dose and time conditions. All opioid ligands, except NAQ and buprenorphine, produced dose-dependent decreases in rates of responding. Ro 64-6198 did not significantly alter mu-opioid ligand rate-decreasing effects. Although these results suggest that NOP agonists may selectively enhance the antinociceptive vs. rate-suppressant effects of some mu-opioid agonists, this small enhancement occurred under a narrow range of conditions dampening enthusiasm for NOP agonists as candidate "opioid-sparing" adjuncts. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
32. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens
- Author
-
Mateo, Yolanda, Budygin, Evgeny A., John, Carrie E., Banks, Matthew L., and Jones, Sara R.
- Subjects
- *
NEUROTRANSMITTERS , *COCAINE , *NARCOTICS , *DRUG addiction , *FLUOXETINE - Abstract
Abstract: Cocaine elevates dopamine (DA) in the nucleus accumbens (NAc) by blocking the uptake of DA through the DA transporter (DAT). It is commonly believed that the reinforcing properties of cocaine depend upon interaction with the DAT, however, cocaine is still reinforcing in mice with a genetic deletion of the DAT (DAT-KO mice). Although cocaine continues being able to elevate DA in the NAc of these mice, this mechanism is unclear. The present voltammetric study in brain slices was designed to examine the role of the norepinephrine and serotonin transporters in removing DA from the extracellular space in the NAc of DAT-KO mice. We found no effects of any monoamine uptake inhibitors, including cocaine (10μM), desipramine (10μM) or fluoxetine (10μM) on the clearance of DA in these mice. Therefore, it appears that there is no compensatory uptake of DA by alternative transporters either in core or shell of the nucleus accumbens of DAT-KO mice. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
33. A drug-vs-food "choice" self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders.
- Author
-
Townsend, E. Andrew, Schwienteck, Kathryn L., Robinson, Hannah L., Lawson, Stephen T., and Banks, Matthew L.
- Subjects
- *
SUBSTANCE abuse , *RATS , *DRUG accessibility , *FENTANYL , *OPIOIDS , *ELECTROACUPUNCTURE - Abstract
• Surgical technique resulted in median first catheter life of 18 weeks. • Intravenous drug-vs-food choice could be trained in rats within ∼27 sessions. • Opioid, stimulant, and opioid + stimulant drug-vs-food choice was established. • Consistency between monkey and rat drug choice results supports translatability. Preclinical drug self-administration procedures are commonly used to investigate expression, mechanisms, and treatment of substance use disorders. The aims were to back-translate an intravenous drug-vs-food choice procedure primarily utilized in monkeys to male and female rats and to develop a surgical method for sustained intravenous catheter patency suitable for long-term drug-choice studies. The surgical protocol resulted in a median intravenous jugular catheter patency in male and female rats of 126 days (range: 25–365 days). Drug-vs-food choice was established with opioids (fentanyl and heroin), psychostimulants (cocaine, methamphetamine, and amphetamine), and an opioid/psychostimulant mixture (fentanyl + methamphetamine). The average time from catheter implantation to stable choice behavior across all drugs was 27 sessions (range: 16–44 sessions). Choice behavior stabilized more quickly for cocaine and fentanyl than for other drugs. Manipulations of both environmental variables (e.g., response requirement or food reinforcer magnitude) and pharmacological variables (e.g., extended access drug self-administration or continuous buprenorphine treatment via osmotic pump) significantly shifted opioid-vs-food choice consistent with previous monkey studies. Duration of intravenous catheter patency in rats was suitable for long-term, within-subject drug choice studies. Effects of environmental and pharmacological manipulations in rats confirmed and extended previous results from monkeys. The concordance of behavioral results between rats and monkeys using the present drug-vs-food choice procedure supports its utility to improve our basic understanding of the expression and mechanisms of substance use disorders towards to development of more effective therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
34. Vaccine blunts fentanyl potency in male rhesus monkeys.
- Author
-
Tenney, Rebekah D., Blake, Steven, Bremer, Paul T., Zhou, Bin, Hwang, Candy S., Poklis, Justin L., Janda, Kim D., and Banks, Matthew L.
- Subjects
- *
RHESUS monkeys , *VACCINES , *BINDING site assay , *NOCICEPTIVE pain , *FENTANYL , *ANTIBODY formation - Abstract
One proposed factor contributing to the increased frequency of opioid overdose deaths is the emergence of novel synthetic opioids, including illicit fentanyl and fentanyl analogues. A treatment strategy currently under development to address the ongoing opioid crisis is immunopharmacotherapies or opioid-targeted vaccines. The present study determined the effectiveness and selectivity of a fentanyl-tetanus toxoid conjugate vaccine to alter the behavioral effects of fentanyl and a structurally dissimilar mu-opioid agonist oxycodone in male rhesus monkeys (n = 3–4). Fentanyl and oxycodone produced dose-dependent suppression of behavior in an assay of schedule-controlled responding and antinociception in an assay of thermal nociception (50 °C). Acute naltrexone (0.032 mg/kg) produced an approximate 10-fold potency shift for fentanyl to decrease operant responding. The fentanyl vaccine was administered at weeks 0, 2, 4, 9, 19, and 44 and fentanyl or oxycodone potencies in both behavioral assays were redetermined over the course of 49 weeks. The vaccine significantly and selectively shifted fentanyl potency at least 10-fold in both assays at several time points over the entire experimental period. Mid-point titer levels correlated with fentanyl antinociceptive potency shifts. Antibody affinity for fentanyl as measured by a competitive binding assay improved over time to approximately 3–4 nM. The fentanyl vaccine also increased fentanyl plasma levels approximately 6-fold consistent with the hypothesis that the vaccine sequesters fentanyl in the blood. Overall, these results support the continued development and evaluation of this fentanyl vaccine in humans to address the ongoing opioid crisis. • Vaccine blunted fentanyl rate-suppression potency ~ 10-fold. • Vaccine blunted fentanyl antinociceptive potency ~25-fold. • Fentanyl vaccine was as effective as acute 0.032 mg/kg naltrexone. • Vaccine was selective for fentanyl versus oxycodone. • Antibody immune response ~ 3 nM affinity for fentanyl. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.